Michael Nelson is currently the Director of Health Economics and Outcomes Research and Real World Evidence at Eisai US, a position held since 2024. Previously, Michael served in various leadership roles, including Director at Sunovion Pharmaceuticals Inc. from 2014 to 2023 and Executive Director at PharmaNet Development Group, Inc. in 2010. Michael's extensive experience also includes being the Vice President of Health Economics and Outcomes Research at both i3 Innovus and Covance. Michael obtained a Certificate in Health Economics and Outcomes Research from UW Professional & Continuing Education between 2019 and 2020.
This person is not in the org chart
This person is not in any teams
This person is not in any offices